Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?

BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is a severe hypersensitivity reaction to aspergillus species colonizing the airways of patients with asthma or cystic fibrosis. Biologics including anti-IgE and anti-IL5 antibodies have strongly changed the treatment of severe asthmatics and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mümmler, Carlo, Kemmerich, Bernd, Behr, Jürgen, Kneidinger, Nikolaus, Milger, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491355/
https://www.ncbi.nlm.nih.gov/pubmed/32944023
http://dx.doi.org/10.1186/s13223-020-00454-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491355/
https://www.ncbi.nlm.nih.gov/pubmed/32944023
http://dx.doi.org/10.1186/s13223-020-00454-w

Ejemplares similares